The Procter & Gamble Company (NYSE:PG) Shares Bought by Schaper Benz & Wise Investment Counsel Inc. WI

Schaper Benz & Wise Investment Counsel Inc. WI raised its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 3.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 23,143 shares of the company’s stock after purchasing an additional 682 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Procter & Gamble were worth $4,008,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Resonant Capital Advisors LLC increased its position in Procter & Gamble by 3.3% during the 3rd quarter. Resonant Capital Advisors LLC now owns 23,461 shares of the company’s stock valued at $4,063,000 after buying an additional 759 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in shares of Procter & Gamble by 7.3% during the third quarter. Revolve Wealth Partners LLC now owns 7,053 shares of the company’s stock worth $1,222,000 after acquiring an additional 478 shares during the last quarter. Veracity Capital LLC increased its holdings in shares of Procter & Gamble by 6.3% during the third quarter. Veracity Capital LLC now owns 3,868 shares of the company’s stock valued at $670,000 after acquiring an additional 229 shares in the last quarter. Wealth Alliance Advisory Group LLC raised its position in shares of Procter & Gamble by 1.4% in the 3rd quarter. Wealth Alliance Advisory Group LLC now owns 17,745 shares of the company’s stock valued at $3,073,000 after purchasing an additional 239 shares during the last quarter. Finally, Waypoint Capital Advisors LLC boosted its stake in Procter & Gamble by 8.2% in the 3rd quarter. Waypoint Capital Advisors LLC now owns 2,340 shares of the company’s stock worth $405,000 after purchasing an additional 177 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

NYSE:PG opened at $171.28 on Friday. The stock has a market capitalization of $404.24 billion, a PE ratio of 27.99, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The stock’s 50-day moving average price is $171.77 and its 200-day moving average price is $167.16.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter last year, the firm posted $1.83 EPS. The business’s revenue was down .6% on a year-over-year basis. As a group, equities analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 65.69%.

Insider Buying and Selling

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

PG has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price target on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Jefferies Financial Group cut Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price target for the stock from $182.00 to $175.00 in a research report on Wednesday, July 24th. Piper Sandler began coverage on Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Finally, Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Nine investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $176.21.

View Our Latest Stock Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.